Fundraising Fox
/Companies
Sign in

Neochord

Maple Grove, US · Founded 2007 · Delaware corporation · 16 employees on LinkedIn · 6 known investors

Find your way into Neochord

Sign up to see every warm intro you have to Neochord

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Neochord team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

NeoChord develops a medical device system for beating heart mitral valve repair in patients with mitral valve regurgitation. The company's flagship product, the NeoChord Artificial Chordae Delivery System, has received CE market clearance in Europe.

Advanced ManufacturingHealthtechMedical Devices

Founders & leadership

TBTodd Berg
Todd BergCEOAdvisor at Vensana Capital
DHDavid H. Chung
David H. ChungPresident & CEO2014–2023
RNRon Nelson
Ron NelsonCFO

Board

CTCasey Tansey
Casey TanseyBoard directorGeneral Partner at US Venture Partners
MK
Mudit K. JainBoard director
AEAndrew ElBardissi
Andrew ElBardissiBoard directorPartner at Deerfield Management Company
ML
Michael LiangBoard director
JA
J. Alex MartinBoard director

Investors · 6

Treo Ventures, Llclisted by Treo Ventures, LlcMinneapolis

How we know: Treo Ventures, Llc's portfolio page · Not right? Tell us

US Venture Partnerslisted by US Venture PartnersMenlo Park · $500K – $10Mvia Casey Tansey · board

How we know: US Venture Partners's portfolio page · board seat on SEC Form D · Not right? Tell us

Deerfield Management CompanyreportedNew Yorkvia Andrew ElBardissi · board

How we know: board seat on SEC Form D · globenewswire.com · Not right? Tell us

U.S. Venture PartnersreportedMinneapolis

How we know: globenewswire.com · Not right? Tell us

Also in the syndicate · 1

Strategic Healthcare Investment Partners (S.H.I.P.)

Reported raises · per SEC filings

Form D private placements

$64.9M disclosed across 11 rounds · 2015–2025

▶$493.2KraisedMar 2025 · 14 investors · Manufacturing
Rule 506(b)
Officers, directors & promoters on the filing
  • Mudit K. JainDirector
  • Casey TanseyDirector
  • Todd BergExecutive Officer, Director
Offering amount
$2.1M
Amount sold
$493.2K
First sale
Feb 2025
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$914.3KraisedAug 2024 · 9 investors · Manufacturing
Rule 506(b)
Officers, directors & promoters on the filing
  • Casey TanseyDirector
  • Mudit K. JainDirector
  • Todd BergExecutive Officer, Director
Offering amount
$2.9M
Amount sold
$914.3K
First sale
Aug 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$4.6MraisedJul 2023 · 3 investors · Manufacturing
Rule 506(b)
Officers, directors & promoters on the filing
  • David NeustaedterDirector
  • Ron NelsonExecutive Officer
  • J. Alex MartinDirector
  • David H. ChungExecutive Officer, Director
  • Mudit K. JainDirector
  • Casey TanseyDirector
  • David GregorkaDirector
Offering amount
$6.8M
Amount sold
$4.6M
First sale
Jun 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2.9MraisedNov 2022 · 25 investors · Manufacturing
Rule 506(b)
Officers, directors & promoters on the filing
  • Ron NelsonExecutive Officer
  • Casey TanseyDirector
  • David GregorkaDirector
  • David H. ChungExecutive Officer, Director
  • J. Alex MartinDirector
  • Andrew ElBardissiDirector
  • Mudit K. JainDirector
Offering amount
$6M
Amount sold
$2.9M
First sale
Sep 2022
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.8MraisedMar 2022 · 6 investors · Manufacturing
Rule 506(b)
Officers, directors & promoters on the filing
  • J. Alex MartinDirector
  • Michael LiangDirector
  • David H. ChungExecutive Officer, Director
  • Andrew ElBardissiDirector
  • Casey TanseyDirector
  • Mudit K. JainDirector
  • Ron NelsonExecutive Officer
Offering amount
$3.5M
Amount sold
$1.8M
First sale
Feb 2022
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1MraisedSep 2021 · 6 investors · Manufacturing
Rule 506(b)
Officers, directors & promoters on the filing
  • Michael LiangDirector
  • Mudit K. JainDirector
  • Andrew ElBardissiDirector
  • Casey TanseyDirector
  • Ron NelsonExecutive Officer
  • David H. ChungExecutive Officer, Director
  • J. Alex MartinDirector
Offering amount
$4M
Amount sold
$1M
First sale
Sep 2021
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2.8MraisedMay 2021 · 6 investors · Manufacturing
Rule 506(b)
Officers, directors & promoters on the filing
  • J. Alex MartinDirector
  • Mudit K. JainDirector
  • Andrew ElBardissiDirector
  • Casey TanseyDirector
  • David H. ChungExecutive Officer, Director
  • Ron NelsonExecutive Officer
  • Michael LiangDirector
Offering amount
$3.9M
Amount sold
$2.8M
First sale
Apr 2021
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$33.4MraisedFeb 2021 · 28 investors · Manufacturing
Rule 506(b)
Officers, directors & promoters on the filing
  • Casey TanseyDirector
  • J. Alex MartinDirector
  • Nicole J. WalkerDirector
  • Andrew ElBardissiDirector
  • Mudit K. JainDirector
  • David H. ChungExecutive Officer, Director
  • Ron NelsonExecutive Officer
Offering amount
$33.5M
Amount sold
$33.4M
First sale
Oct 2018
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Founder mafia

3 people who came through Neochord went on to found or lead other companies.

Michael DaleMember of Board of DirectorsFounded Axogeninc +2Todd BergExecutive Officer, DirectorFounded Metavention +1Mudit K. JainBoard Of DirectorsFounded ShiraTronics

In the news

NeoChord Raises Additional Financing to Drive Catheter‐based Program Development, Bringing Total Series D Funding to over $32 Million | NeoChordneochord.com · Apr 2019NeoChord Raises Additional Financing to Drive Catheter-based Program Development, Bringing Total Series D Funding to over $32 Millionglobenewswire.com · Apr 2019

Frequently asked questions

What does Neochord do?
NeoChord develops a medical device system for beating heart mitral valve repair in patients with mitral valve regurgitation. The company's flagship product, the NeoChord Artificial Chordae Delivery System, has received CE market clearance in Europe.
Who are Neochord's investors?
Neochord's investors include Baird Capital, Treo Ventures, Llc, US Venture Partners, Deerfield Management Company, U.S. Venture Partners.
How much funding has Neochord raised?
Neochord has disclosed $64.9M raised across 11 rounds.
Where is Neochord headquartered?
Neochord is headquartered in Maple Grove, US.